Comparison
6q Terminal Deletion Syndrome C4304514 vs 22q Related Schwannomatosis Cn378756
Clinical comparison between 6Q Terminal Deletion Syndrome and 22q Related Schwannomatosis CN378756 for differential diagnosis and treatment planning.
6q Terminal Deletion Syndrome C4304514
A chromosomal disorder involving deletion of genetic material at the end of chromosome 6, leading to developmental delays and variable physical features.
22q Related Schwannomatosis Cn378756
A rare genetic condition linked to chromosome 22, causing multiple benign nerve tumors called schwannomas. Can cause pain and other symptoms. Managed with surgery and pain control.
6 comparison axes
Onset
6q Terminal Deletion Syndrome C4304514
0-0
22q Related Schwannomatosis Cn378756
20-50
Onset patterns differ
Severity
6q Terminal Deletion Syndrome C4304514
severe
22q Related Schwannomatosis Cn378756
moderate
Different severity levels
Chronic
6q Terminal Deletion Syndrome C4304514
Chronic
22q Related Schwannomatosis Cn378756
Chronic
Differing course
Communicable
6q Terminal Deletion Syndrome C4304514
No
22q Related Schwannomatosis Cn378756
No
Different transmission
Body System
6q Terminal Deletion Syndrome C4304514
congenital
22q Related Schwannomatosis Cn378756
neurologic
Same/different system
Category
6q Terminal Deletion Syndrome C4304514
genetic
22q Related Schwannomatosis Cn378756
oncology
Different category
Bottom line
6q-terminal-deletion-syndrome-C4304514 and 22q-related-schwannomatosis-CN378756 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 6q Terminal Deletion Syndrome C4304514 | 22q Related Schwannomatosis Cn378756 | Discriminating power |
|---|---|---|---|
| Age at recognition | Described from birth or infancy | Typically recognized around ages 20–50 | High |
| Main clinical pattern | Developmental delay with variable physical features | Multiple benign nerve tumors, often with pain | High |
| Primary clinical domain | Congenital genetic developmental disorder | Neurologic tumor-related condition | Moderate |
When to favor each condition
Choose 6q Terminal Deletion Syndrome C4304514 when
Infant with suspected chromosomal deletion
Matches congenital onset and terminal 6q deletion
High
Developmental delay without adult nerve tumors
The supplied pattern emphasizes development, not schwannomas
Moderate
Counseling for a copy-number disorder
Category is genetic and congenital rather than tumor predisposition
Moderate
Choose 22q Related Schwannomatosis Cn378756 when
Adult with multiple painful nerve tumors
Fits later onset and schwannoma description
High
Care focused on tumor symptoms
Supplied management includes surgery and pain control
Moderate
Suspected chromosome 22 tumor predisposition
Distinct chromosome, category, and clinical course from 6q deletion
High
How key tests differ
| Test | 6q Terminal Deletion Syndrome C4304514 | 22q Related Schwannomatosis Cn378756 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May identify a terminal chromosome 6 deletion | Not expected to show that deletion | A confirmed deletion supports the left; absence does not diagnose the right. |
| Targeted germline genetic testing | Not defined as the principal test here | May support a related predisposition when indicated | Exact genes are not supplied; specialist interpretation is required. |
| MRI of symptomatic regions | No characteristic tumor pattern is established | May localize schwannomas linked to symptoms | Imaging supports localization but does not alone prove either diagnosis. |
Prognosis comparison
6q Terminal Deletion Syndrome C4304514
- Outcome
- Lifelong congenital condition with potentially severe developmental effects; exact outcomes are not established.
- Factors
- Deletion extent, anomalies, supports, and comorbidities may influence course.
22q Related Schwannomatosis Cn378756
- Outcome
- Chronic moderate condition; benign tumors may still cause persistent pain or neurologic symptoms.
- Factors
- Tumor number, location, pain, deficits, and surgery may affect course.
Time frame: Left begins at birth; right often starts in adulthood and may persist.
Individual genetics, symptom burden, and specialist care matter; no mortality comparison is established.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impairment | Delays are described and may be substantial Not a defining early feature in the source Functional impact varies; no specific disability profile is established. |
| Chronic pain | Not established as the principal feature Pain is a recognized schwannoma-related symptom Pain may drive care even though tumors are described as benign. |
| Procedural burden | No specific procedural course is established Selected symptomatic tumors may require surgery Indications and risks need individualized clinical assessment. |
Patient education highlights
- HighDistinct conditions
These conditions differ in age, features, chromosome, and usual care goals.
- HighTransmission
Neither is communicable; both are described as genetic conditions.
- MediumFollow-up
Genetics and relevant specialists should interpret results and plan monitoring.